IMMUNPROTEASOMINHIBITOREN

European patent · EP3571208 · Deleted

Register entry

Publication number
EP3571208
Application number
EP18716009
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 16, 2018
Published
Nov 27, 2019
Granted
Mar 10, 2021
Deleted
Aug 25, 2026
Reason
Annual fee unpaid
IPC classes
C07F 5/02 (2006.01)
A61K 31/69 (2006.01)
A61P 37/00 (2006.01)
Priority
US 201762447717 P 18.01.2017
US 201762508771 P 19.05.2017
PCT application
PCT/US2018/013823 16.01.2018
PCT publication
WO2018/136401 26.07.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 25, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.08.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.08.2026

  2. Feb 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jan 19, 2022

    Change

    Published in Swissreg on 19.01.2022

  6. Apr 20, 2021

    Agent entered

    Representative
    Ing. Marco Zardi, c/o M. ZARDI & Co. S.A., via Pioda 6, 6900 Lugano

    Published in Swissreg on 20.04.2021

  7. Mar 10, 2021

    Granted

    Published in Swissreg on 10.03.2021

Parties

Inventor

LOU, Yan

South San Francisco CA 94080, US

OWENS, Timothy, Duncan

South San Francisco CA 94080, US

BRAMELD, Kenneth, Albert

South San Francisco CA 94080, US

GOLDSTEIN, David, Michael

South San Francisco CA 94080, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.